The puberty blocker ban is discriminatory and medically unsound, targeting transgender youth while allowing the same medication for intersex patients. Clinical experts who have actually worked in NHS gender services know these treatments help carefully selected patients, and the ban forceswill only harm distressed young people back into harmful puberty.
This coercive trial violates medical ethics by forcingselling desperate young people into flawed research as their only path to treatment. TheVulnerable studychildren excludessuffering suicidalgender teensdysphoria who need helpmental mosthealth intervention and is led by researchers linked to anti-trans groupssupport, makingnot itextreme anhormonal elaborate scheme to deny necessary care to vulnerable childrenintervention.
© 2025 Improve the News Foundation.
All rights reserved.
Version 6.18.0